Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
PaperCitations, authors & open-access status
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 174 citations, 2017 year and hybrid oa status.
174
Citations
2017
Year
hybrid
OA Status